xFOREST Therapeutics

xFOREST Therapeutics is a Kyoto-based young biotech company. At xFOREST, we develop a proprietary screening pipeline to find RNA-targeting small molecules with the goal to develop them into new drugs that treat previously untreatable diseases. Our pipeline includes both a highly automated laboratory system of liquid- and labware-handling devices and an automated analysis pipeline capable of statistically analyzing millions of potential RNA-small molecule interactions flagging promising hit-pairs. Our vision is to become a next-generation discovery platform that utilizes synergies between wet and dry lab, based on big data and AI

Xforest therapeutics operates in the Pharmaceutical manufacturing industry.

Xforest therapeutics's revenue is 11m - 100m

Xforest therapeutics has 11 - 50 employees.